About this trial
Collect clinical history and treatment data of AD in adulthood;
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Age 18 years
Signature of informed consent
EASI 16
location in at least one of the following "critical" locations: face, hands, genitals
Disqualifiers
Patient unable to provide informed consent prior to any collection procedures data on the study;
unable to complete the procedures required for the study;
a patient already participating in another follow-up register of the same disease.
Trial population
The nature of the study is descriptive. Each centre undertakes to recruit all adult patients diagnosed with moderate-severe atopic dermatitis observed at the center.
Trial design
Cohort
Prospective
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
Epidemiological data
Reassessment of the epidemiology of AD
Identification of factors for specific treatment
Assessment of treatment profiles and identification of factors that determine the decision about the specific treatment of moderate and severe AD
clinical and therapeutic data
Assessment of any comorbidities;
characterization of diagnostic criteria
Outlining possible diagnostic criteria specific to AD in adults;
Sponsors and contacts
Click on the lead sponsor to view all of their trials.